Atlas Trials

Effects of Immulina TM Supplements With PASC Patients

Clinical trial NCT05524532 · COMPLETED

Trial details

NCT number
NCT05524532
Sponsor
University of Mississippi Medical Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Post Acute COVID-19 Syndrome
Start date
2023-07-20
Primary completion
2025-07-29
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.